Literature DB >> 26315517

Lung Cancer Screening.

Mark E Deffebach1, Linda Humphrey2.   

Abstract

Screening for lung cancer in high-risk individuals with annual low-dose computed tomography has been shown to reduce lung cancer mortality by 20% and is recommended by multiple health care organizations. Lung cancer screening is not a specific test; it is a process that involves appropriate selection of high-risk individuals, careful interpretation and follow-up of imaging, and annual testing. Screening should be performed in the context of a multidisciplinary program experienced in the diagnosis and management of lung nodules and early-stage lung cancer. Published by Elsevier Inc.

Entities:  

Keywords:  Low Dose CT; Multidisciplinary program; Screening; Smoking

Mesh:

Year:  2015        PMID: 26315517     DOI: 10.1016/j.suc.2015.05.006

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  8 in total

1.  A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.

Authors:  Yanding Zhao; Frederick S Varn; Guoshuai Cai; Feifei Xiao; Christopher I Amos; Chao Cheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

2.  Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.

Authors:  Ana I Robles; Curtis C Harris
Journal:  Lung Cancer       Date:  2016-06-14       Impact factor: 5.705

3.  Hsa_circ_0102533 serves as a blood-based biomarker for non-small-cell lung cancer diagnosis and regulates apoptosis in vitro.

Authors:  Xiao Zhou; Hong-Yan Liu; Wen-Yan Wang; Hui Zhao; Tong Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

4.  Trends in lung cancer screening in the United States, 2016-2017.

Authors:  Ikenna C Okereke; Shawn Nishi; Jie Zhou; James S Goodwin
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

Review 5.  Rare occurrence of metastasis from lung cancer to the anus: case report and review of the literature.

Authors:  Mohannad Al-Tarakji; Jonas Feilchenfeldt; Abdulrazzaq Haidar; Lajos Szabados; Sherif Abdelaziem; Ali Sayed; Adriana Toro; Isidoro Di Carlo
Journal:  World J Surg Oncol       Date:  2016-06-08       Impact factor: 2.754

6.  Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer.

Authors:  Qian Shao; Shanshan Liu; Wei Wang; Yingjie Zhang; Fengxiang Li; Jianbin Li
Journal:  Onco Targets Ther       Date:  2017-01-31       Impact factor: 4.147

7.  Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.

Authors:  Nan Gao; Baoguo Ye
Journal:  Cancer Cell Int       Date:  2020-01-03       Impact factor: 5.722

8.  Duration of intervals in the care seeking pathway for lung cancer in Bangladesh: A journey from symptoms triggering consultation to receipt of treatment.

Authors:  Adnan Ansar; Virginia Lewis; Christine Faye McDonald; Chaojie Liu; Muhammad Aziz Rahman
Journal:  PLoS One       Date:  2021-09-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.